Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Wuhan Dazhong Dental Medical CoHKSE:02651 -6.82%22 Return-on-Tangible-Equity is 15.30% as of Dec. 2025, which is 80% below its 10-year median of 77.76. GuruFocus rates HKSE:02651 with a GF Score™ of 22/100. The stock has 4 warning signs investors should review. Among 586 Healthcare Providers & Services companies, Wuhan Dazhong Dental Medical Co ranks better than 70.14% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Wuhan Dazhong Dental Medical Co's annualized net income for the quarter that ended in Dec. 2025 was HK$27.2 Mil. Wuhan Dazhong Dental Medical Co's average shareholder tangible equity for the quarter that ended in Dec. 2025 was HK$177.5 Mil. Therefore, Wuhan Dazhong Dental Medical Co's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was 15.30%.
The historical rank and industry rank for Wuhan Dazhong Dental Medical Co's Return-on-Tangible-Equity or its related term are showing as below:
HKSE:02651'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 18.53 Med: 77.76 Max: 85.5
Current: 22.68
During the past 4 years, Wuhan Dazhong Dental Medical Co's highest Return-on-Tangible-Equity was 85.50%. The lowest was 18.53%. And the median was 77.76%.
HKSE:02651's Return-on-Tangible-Equity is ranked better than 70.14% of 586
companies
in the Healthcare Providers & Services industry
Industry Median: 10.74
vs HKSE:02651: 22.68
Wuhan Dazhong Dental Medical Co (HKSE:02651) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Wuhan Dazhong Dental Medical Co Return-on-Tangible-Equity Related Terms
Wuhan Dazhong Dental Medical Co Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wuhan Dazhong Dental Medical Co Return-on-Tangible-Equity Chart
HKSE:02651 vs HCA, THC, EHC: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Wuhan Dazhong Dental Medical Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wuhan Dazhong Dental Medical Co Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Wuhan Dazhong Dental Medical Co's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Wuhan Dazhong Dental Medical Co's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 15.30% mean?
Wuhan Dazhong Dental Medical Co (HKSE:02651) has a Return-on-Tangible-Equity of 15.30% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Wuhan Dazhong Dental Medical Co and its competitors. This is 80% below median its historical median of 77.76. Over the past decade, Wuhan Dazhong Dental Medical Co's Return-on-Tangible-Equity has ranged from 18.53 to 85.50. According to the industry distribution chart, Wuhan Dazhong Dental Medical Co ranks #175 out of 586 companies in the Healthcare Providers & Services industry, placing it in the top 29.9%.
Is Wuhan Dazhong Dental Medical Co's Return-on-Tangible-Equity too high?
Wuhan Dazhong Dental Medical Co's current Return-on-Tangible-Equity of 15.30% is 80% below median its 10-year median of 77.76. Over the past 10 years, this metric has ranged from a low of 18.53 to a high of 85.50. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.74. Wuhan Dazhong Dental Medical Co's value of 15.30% is 42.5% above this industry median. Based on the distribution chart, Wuhan Dazhong Dental Medical Co ranks #175 out of 586 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Wuhan Dazhong Dental Medical Co has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Wuhan Dazhong Dental Medical Co's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Wuhan Dazhong Dental Medical Co ranks #175 out of 586 companies for Return-on-Tangible-Equity. This puts Wuhan Dazhong Dental Medical Co in the upper half of its industry. The industry median Return-on-Tangible-Equity is 10.74. Wuhan Dazhong Dental Medical Co's value of 15.30% is 42.5% above this benchmark. Historically, Wuhan Dazhong Dental Medical Co's own Return-on-Tangible-Equity has ranged from 18.53 to 85.50 over the past decade. While the company's 10-year median is 77.76 vs. the industry median of 10.74, Wuhan Dazhong Dental Medical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.74, based on 586 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wuhan Dazhong Dental Medical Co's current Return-on-Tangible-Equity of 15.30% is 42.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Wuhan Dazhong Dental Medical Co and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wuhan Dazhong Dental Medical Co's current Return-on-Tangible-Equity is 15.30%, which is 80% below median its own 10-year median of 77.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wuhan Dazhong Dental Medical Co stock overvalued right now?
Wuhan Dazhong Dental Medical Co (HKSE:02651) has a current Return-on-Tangible-Equity of 15.30%. The current Return-on-Tangible-Equity is 15.30%, which is 80% below median its 10-year median of 77.76 and 42.5% above the Healthcare Providers & Services industry median of 10.74. Wuhan Dazhong Dental Medical Co's overall GF Score™ is 22/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Wuhan Dazhong Dental Medical Co (HKSE:02651), the current Return-on-Tangible-Equity is 15.30% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Wuhan Dazhong Dental Medical Co Ltd is a dental services provider in Central China with a focus on Hubei and Hunan provinces, operating an expanding dental service network. The company operates a Partnership Program targeting seasoned medical professionals, to underpin the expansion of its dental service network, maintain the cohesion and stability of its core talent team and facilitate its talent team development, all of which constitute its competitive advantages and make its dental service network an ideal entrepreneurial platform for dentists.
22GF Score
Get the complete analysis for HKSE:02651
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02651 has been successfully added to your 
